SCHEMBL10703140

SCHEMBL10703140

C=C1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(OC(C)=O)C(C)=O)[C@]2(C)C1=CC(=O)[C@@H]1C[C@@H]12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 7/20 0.65
▸ NR3C1 P04150 7/20 0.65
▸ PGR P06401 7/20 0.65
▸ AR P10275 6/20 0.65
▸ LMNA P02545 4/20 0.65
▸ ALDH1A1 P00352 3/20 0.65
▸ CHRM2 P08172 3/20 0.65
▸ CYP2C9 P11712 3/20 0.65
▸ MAPK1 P28482 3/20 0.65
▸ MAPT P10636 1/20 0.65
▸ TSHR P16473 1/20 0.65
▸ OPRM1 P35372 1/20 0.65
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ NPSR1 Q6W5P4 3/20 0.48
▸ ABCB11 O95342 2/20 0.48
▸ CHRM1 P11229 2/20 0.48
▸ USP2 O75604 2/20 0.48
▸ ABCC4 O15439 1/20 0.48
▸ ESR1 P03372 1/20 0.48
▸ SHBG P04278 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10703057 0.91 CYP3A4 (0.54) CYP3A4NR3C1PGRARLMNA
SCHEMBL10705486 0.89 NR3C1 (0.53) CYP3A4NR3C1PGRARLMNA
SCHEMBL10706225 0.89 NR3C1 (0.52) CYP3A4NR3C1PGRARLMNA
SCHEMBL10703728 0.87 CYP3A4 (0.50) CYP3A4NR3C1PGRARLMNA
SCHEMBL10704394 0.87 CYP3A4 (0.55) CYP3A4NR3C1PGRARLMNA
SCHEMBL10702508 0.84 NR3C1 (0.63) CYP3A4NR3C1PGRARLMNA
SCHEMBL11799696 0.81 CYP3A4 (0.60) CYP3A4NR3C1PGRARLMNA
SCHEMBL10705465 0.81 CYP3A4 (0.60) CYP3A4NR3C1PGRARLMNA
SCHEMBL10705553 0.81 CYP3A4 (0.49) CYP3A4NR3C1PGRARLMNA
SCHEMBL10705560 0.81 CYP3A4 (0.49) CYP3A4NR3C1PGRARLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0153270-B1 1-ALPHA, 2-ALPHA-METHYLENE-6-METHYLENE AND 6-ALPHA-METHYL PREGNENES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 — — EP claimed
US-4670427-A ANTIANDROGENS SCHERING AKTIENGESELLSCHAFT (DE) 1987-06-02 — — US claimed
EP-0153270-B1 1-ALPHA, 2-ALPHA-METHYLENE-6-METHYLENE AND 6-ALPHA-METHYL PREGNENES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 — — EP disclosed
US-4670427-A ANTIANDROGENS SCHERING AKTIENGESELLSCHAFT (DE) 1987-06-02 — — US disclosed
EP-0153270-A2 1-Alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1985-08-28 — — EP disclosed
Send feedback